<DOC>
	<DOCNO>NCT02530788</DOCNO>
	<brief_summary>This plan pilot study monocentric , prospective , double-blind randomize placebo control clinical study . The SOS-LVAD Trial assign clinical Phase III . The aim present trial provide scientific rationale large multicenter clinical trial , investigate effect perioperative high dose selenium supplementation high-risk cardiac surgical patient undergo complicate open heart surgery prolong time cardiopulmonary bypass ( CPB ) LVAD Implant . The investigator hypothesize therapeutic strategy test randomized trial may contribute fast independency life-sustaining technology ICU decrease postoperative morbidity mortality . Before proceed large-scale , definitive trial , investigator propose conduct pilot study definitive randomize trial , determine feasibility study protocol .</brief_summary>
	<brief_title>High-dose Selenium Supplementation Patients With Left Ventricular Assist</brief_title>
	<detailed_description />
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Selenious Acid</mesh_term>
	<mesh_term>Sodium Selenite</mesh_term>
	<criteria>Inclusion criterion : Patients chronic leave ventricular heart failure , undergo LVAD Implant surgery ( include heart surgery ) Full age , contractually capable , male female patient Patients capable willing understand obey instruction study staff . Signed informed consent Exclusion criterion : Selenium intoxication Patients contraindication plan intervention , due disease Severe exacerbation comorbidities renal failure require dialysis liver dysfunction ( define bilirubin &gt; 2mg/dl ) Known hypersensitivity trial medication ( selenase® 300 RP , selenase® T ) , constituent solution placebo Patients contractually capable ; Patients accommodate facility court order public authority Pregnancy lactation period Women reproductive age , without suitable contraception Patients relationship dependency employment head study 's Underaged No sign inform consent Simultaneous participation another clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Cardiac Surgery</keyword>
	<keyword>Ventricular Assist Device</keyword>
	<keyword>Selenium</keyword>
</DOC>